Stereotactic body RT promising for low-, intermediate-risk PCa
(HealthDay)—In men with low-risk and intermediate-risk prostate cancer, stereotactic body radiotherapy is associated with low rates of severe toxic events and high rates of biochemical control, according to a study published ...
Mar 5, 2019
0
1